Hippocrates and prognosis in heart failure: The challenge of static and dynamic measurements

American Heart Journal

Volumn 146, Issue 2, 2003, Pages 215-217

  Ventura, Hector O ^a   Mehra, Mandeep R ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE SEVERITY; EDITORIAL; HEART FAILURE; HIGH RISK PATIENT; MEASUREMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0041626018     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00234-5     Document Type: Editorial

References (16)

1. Hippocrates. The book of prognostics. In: Adams F, editor. The genuine works of Hippocrates, volume I. London: C&J Adlars Printers; 1849. p. 234.
2. Mehra MR, Ventura HO. Heart failure. In: Civetta JM, Taylor RW, Kirby RR, editors. Critical care. 3rd ed. Philadelphia: J.B. Lippincott Company; 1997. p. 1887-903.
3. Hunt S, Baker D, Chin M, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2001;38:2101-13.
4. Cowburn P, Cleland J, Coats A, et al. Risk stratification in chronic heart failure. Eur Heart J 1998;19:696-710.
5. Mancini D, LeJemtel T, Aaronson K. Peak VO2: A simple yet enduring standard. Circulation 2000;101:1080-2.
6. Milani RV, Mehra MR, Reddy T, et al. Ventilation/carbon dioxide production ratio in early heart exercise predicts poor functional capacity in congestive heart failure. Heart 1996;76:393-6.
7. Osman AF, Lavie CJ, Mehra MR, et al. The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J Am Coll Cardiol 2000;36:2126-31.
8. Packer M, Fowler MB, Roecker EB, et al. Effect of carvedilol on the morbidity of patients with sever chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002;106:2194-9.
9. Stevenson L, Steimle A, Fonarow G, et al. Improvement in exercise capacity of candidates awaiting heart transplantation. J Am Coll Cordiol 1995;25:163-70.
10. Florea, Henein M, Anker S, et al. Prognostic value of changes over time in exercise capacity and echocordiographic measurements in patients with chronic heart failure. Eur Heart J 2000;21:146-53.
11. Levine T, Levine A, Goldberg A, et al. Reversal of end stage heart failure is predicted by long term therapeutic response rather than initial hemodynamic and neurohormonal profile. J Heart Lung Transplant 1996;15:297-303.
12. Gullestad L, Myers J, Ross H, et al. Serial exercise testing and prognosis in slected patients considered for heart transplantation. Am Heart J 1998;135:221-9.
13. Grigioni F, Barbieri A, Magnani G, et al. Serial versus isolated assessment of clinical and instrumental parameters in heart failure: prognostic and therapeutic implications. Am Heart J 2003;146:298-303.
14. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in heart failure. N Engl J Med 2002;346:1845-53.
15. Zugck C, Haunstetter A, Kruger C, et al. Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. J Am Coll Cordiol 2002;15:1615-22.
16. Hippocrates. The book of prognostics. In: Adams F, editor. The genuine works of Hippocrates, volume I. London: C&J Adlars Printers; 1849. p. 18.